Dystrophie musculaire de Duchenne Dystrophie musculaire de Duchenne Dystrophie musculaire de Duchenne

News

Hope for Duchenne muscular dystrophy
By La Force DMD
In News
Posted 6 September 2016

Hope for Duchenne muscular dystrophy

Today, September 7th is an international “Duchenne Awareness Day.” We took this opportunity to launch our video. It aims to inform the public about Duchenne muscular dystrophy and new [...]

The DMD community meets the FDA – Part – 2
By La Force DMD
In News
Posted 30 April 2016

The DMD community meets the FDA – Part – 2

The DMD community meets the FDA at the AdCom conference. Testimonial, part 2. Indeed, it was tough for me to attend the AdCom Conference. Throughout the day, monuments of data were built and [...]

The Duchenne muscular dystrophy community meets the FDA – Part-1
By La Force DMD
In News
Posted 30 April 2016

The Duchenne muscular dystrophy community meets the FDA – Part-1

On April 25, two representatives from the Force traveled to Washington, DC, to attend the AdCom Conference of the Food & Drug Administration (FDA), which focused on the approval of new [...]

Joining Forces To Finance a Promising Research Project on OPG
By La Force DMD
In News, Research
Posted 22 March 2016

Joining Forces To Finance a Promising Research Project on OPG

La Force is proud to announce its participation in the funding of a promising research project on osteoprotegerin, also known as “OPG”. Invited to Boston by the Duchenne Alliance specialists [...]

Diseases rarer than February 29th!
By La Force DMD
In News
Posted 1 March 2016

Diseases rarer than February 29th!

Did you know that February is the Rare Disease Month? And that February 29th, a rare day that only happens four years is International Rare Disease Day? Read more DMD is also a Zebra Because it [...]

Understanding the genetic condition of your child with DMD
By La Force DMD
In News
Posted 21 July 2015

Understanding the genetic condition of your child with DMD

Marie-Catherine Du Berger, President Fondation La Force, Duchenne Muscular Dystrophy In our family, the diagnostic hit on October 2013: our son Anakin is stricken with DMD.  The only thing I can [...]

1 2 3 4 5 6 7 8
page 1 of 8

Articles récents

  • The global day of giving
  • EMBARK, gene therapy for the treatment of DMD
  • Part B of MOMENTUM study of SRP-5051 in patients with DMD
  • World Duchenne Awareness Day 2021
  • ENDEAVOR, gene therapy for DMD

Catégories

  • Fundraising
  • in the Medias
  • News
  • Research
  • Testimonial
  • Treatments

+

Restez informé

    LA Force - Dystrophie musculaire de Duchenne

    La Force dmd - Tous droits réservés - Organisme de bienfaisance enregistré : 817683568RP0001
    La Force dmd La Force dmd
    • S’informer
      • Frequently Asked Questions
    • Make a Donation
    • Agir
      • Quick guige – Management of DMD
      • Take action – What’s your genetic profile?
      • Take action – Subscribe to registries
    • Aller plus loin
      • Go further – How can you access a new treatment?
      • Go further – How do researchers test new treatments?
      • Go further – How are drugs approved for use in Canada?
      • Go further – Who decides to reimburse drug costs?
    • Blog
    • About us
    • Contact-us
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistiques
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    View preferences
    {title} {title} {title}